This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kanetsky, P. A. Articles by Rebbeck, T. R. Search for Related Content PubMed PubMed Citation Articles by Kanetsky, P. A. Articles by Rebbeck, T. R.

Interaction of Glutathione S-Transferase M1 and T1 Genotypes and Malignant Melanoma¹

Departments of Biostatistics and Epidemiology [P. A. K., R. H., A. W., D. N., J. S., T. R. R.] and Medicine, Division of Hematology-Oncology [D. G.], University of Pennsylvania, Philadelphia, Pennsylvania 19104, and Department of Dermatology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [A. H.]

The µ and classes of glutathione S-transferases (GST) may affect the development of cutaneous malignant melanoma (CMM) by decreasing cellular oxidative stress in skin. These isozymes are absent in a large proportion of the population because of germ-line homozygous deletions in the genes encoding GSTM1 and GSTT1. To determine the association between GSTM1 and GSTT1 homozygous deletions (GSTM1 null and GSTT1 null, respectively) and CMM, we studied 212 patients with CMM, 150 patients with CMM and dysplastic nevi (DN), 147 patients with DN alone, and 124 healthy persons without CMM or DN. Comparing CMM cases (n = 362) to participants without CMM (n = 271), we found no association with GSTM1 null [odds ratio (OR), 1.2; 95% confidence interval (CI), 0.86–1.6] or GSTT1 null (OR, 0.82; 95% CI, 0.56–1.2), either independently or in combination (OR, 1.4; 95% CI, 0.81–2.2), after adjusting for age. However, among the subset of participants with red or blond hair, those with CMM were twice as likely to carry GSTM1 null (OR, 2.2; 95% CI, 1.2–4.2) and nearly 10-fold more likely to carry both GSTM1 null and GSTT1 null (OR, 9.5; 95% CI, 1.2–73) compared with those without CMM. These data suggest that among persons with hair colors traditionally associated with increased risk for melanoma, absence of both GSTM1 and GSTT1 may act to further elevate CMM risk.

This article has been cited by other articles:

				J. M. Marzec, J. D. Christie, S. P. Reddy, A. E. Jedlicka, H. Vuong, P. N. Lanken, R. Aplenc, T. Yamamoto, M. Yamamoto, H.-Y. Cho, et al. Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury FASEB J, July 1, 2007; 21(9): 2237 - 2246. [Abstract] [Full Text] [PDF]

				N. Soufir, R. Meziani, J.-J. Lacapere, G. Bertrand, F. Fumeron, A. Bourillon, B. Gerard, V. Descamps, B. Crickx, L. Ollivaud, et al. Association Between Endothelin Receptor B Nonsynonymous Variants and Melanoma Risk J Natl Cancer Inst, September 7, 2005; 97(17): 1297 - 1301. [Abstract] [Full Text] [PDF]

				S. Jackson, M. Harland, F. Turner, C. Taylor, P. A. Chambers, J. Randerson-Moor, A. J. Swerdlow, I. dos Santos Silva, S. Beswick, D. T. Bishop, et al. No Evidence for BRAF as a Melanoma/Nevus Susceptibility Gene Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 913 - 918. [Abstract] [Full Text] [PDF]

				P. A. Kanetsky, F. Ge, D. Najarian, J. Swoyer, S. Panossian, L. Schuchter, R. Holmes, D. Guerry, and T. R. Rebbeck Assessment of Polymorphic Variants in the Melanocortin-1 Receptor Gene with Cutaneous Pigmentation Using an Evolutionary Approach Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 808 - 819. [Abstract] [Full Text] [PDF]

				E Matichard, P Verpillat, R Meziani, B Gerard, V Descamps, E Legroux, M Burnouf, G Bertrand, F Bouscarat, A Archimbaud, et al. Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure J. Med. Genet., February 1, 2004; 41(2): e13 - 13. [Full Text] [PDF]